(Date:3/21/2010)... , March 21 Family Research Council President Tony Perkins released the following statement in response to reports that President ... ... , , ... ... ...
(Date:3/21/2010)... first time in humans, scientists used RNA to ... March 21 (HealthDay News) -- For the first ... gene-manipulation therapy to enter tumor cells and block ... cancer, researchers report. , "They,re basically putting ... don,t want this protein expressed for now," explained ...
(Date:3/18/2010)... ... and Still Afford Flowers for your Mom , ... Westport, CT (Vocus) March 18, 2010 -- This Mother’s Day, Save the Children has a ... poorest, most remote communities in the world. For as little as $13 you can buy, ...
(Date:3/18/2010)... ... cosmetic and plastic surgery patients. The Plastic Surgery Institute of Southeast Texas provides their patients ... ... well-used in cosmetic surgery procedures. It is also one of the top concerns for people ...
(Date:3/18/2010)... , ... , ... ... WASHINGTON , March 18 Kids in Minnesota will take center stage in the fight against tobacco on ...
Breaking Medicine News(10 mins):Health News:Executive Order Will In No Way Prevent Federal Funding of Elective Abortion 2Health News:Executive Order Will In No Way Prevent Federal Funding of Elective Abortion 3Health News:Executive Order Will In No Way Prevent Federal Funding of Elective Abortion 4Health News:Gene-Targeted Cancer Fix Could Be a Breakthrough 2Health News:Gene-Targeted Cancer Fix Could Be a Breakthrough 3Health News:A Mother's Day Gift that Gives Lasting Joy 2Health News:Plastic Surgery Institute of Southeast Texas Offers Milder Anesthesia for Outpatient Procedures 2Health News:Minnesota Kids 'Kick Butts' on March 24 2Health News:Minnesota Kids 'Kick Butts' on March 24 3Health News:Minnesota Kids 'Kick Butts' on March 24 4Health News:Minnesota Kids 'Kick Butts' on March 24 5... nurses believe that people with Borderline Personality Disorder (BPD) receive ... suffer from the condition, according to the October issue of ... per cent of nurses said service shortages played a role ... between staff on how to care for people with BPD ...
... York, NYHealth insurance reform plans that build on a ... are shared among government, employers, and enrollees would have ... and would be the most practical to implement according ... Fund Commission on a High Performance Health System. Commissioners ...
... Homeopathy ... By Dana Ullman, MPH Foreword by Dr. Peter ... There is a good reason that 11,American presidents, 7 popes, Charles ... advocated for,homeopathic treatment: homeopathy works! The majority of people in Western ...
... Two Arizona-based philanthropic organizations have committed $45 ... personalized molecular diagnostics. The ability to diagnose and ... makeup is critical to enabling physicians to improve ... medical costs. , Under the Partnership for ...
... of tumor response ... and accelerates drug development, SEATTLE, Oct. 18 ... Medicine, LLC (SM), a,wholly-owned subsidiary of CTI, today announced the ... of brostallicin used in combination,with either bevacizumab or irinotecan, for ...
... and exhibitors registered for the,first-ever HIMSS Virtual Conference ... 17 With studies from the,National Center for ... enrolling in distance education in the United States ... Systems Society (HIMSS),will host its second exclusively online ...
Other Medicine News:Health News:Services for patients with BPD need to be improved say psychiatric nurses 2Health News:Services for patients with BPD need to be improved say psychiatric nurses 3Health News:New report: private/public insurance mix is most practical way to achieve universal coverage 2Health News:New report: private/public insurance mix is most practical way to achieve universal coverage 3Health News:New report: private/public insurance mix is most practical way to achieve universal coverage 4Health News:The Homeopathic Revolution 2Health News:The Homeopathic Revolution 3Health News:Virginia G. Piper Charitable Trust and Flinn Foundation launch molecular diagnostics initiative 2Health News:Virginia G. Piper Charitable Trust and Flinn Foundation launch molecular diagnostics initiative 3Health News:Virginia G. Piper Charitable Trust and Flinn Foundation launch molecular diagnostics initiative 4Health News:U.S. Oncology Initiates Complete Phase Ib Trial of Brostallicin Combination Therapy in Advanced Solid Tumors 2Health News:U.S. Oncology Initiates Complete Phase Ib Trial of Brostallicin Combination Therapy in Advanced Solid Tumors 3Health News:U.S. Oncology Initiates Complete Phase Ib Trial of Brostallicin Combination Therapy in Advanced Solid Tumors 4Health News:HIMSS' Second Virtual Conference & Expo Less Than a Month Away 2Health News:HIMSS' Second Virtual Conference & Expo Less Than a Month Away 3Health News:HIMSS' Second Virtual Conference & Expo Less Than a Month Away 4... seeks to wean certain kidney transplant recipients off,anti-rejection ... After a transplant surgery,anti-rejection drugs for the organ ... have serious side effects, including infections, heart disease ... a researcher at Northwestern,University,s Feinberg School of Medicine, ...
... II Investigational Trial Published in CANCER: the Journal of the ... ... Cell Therapeutics, Inc.,(CTI) (Nasdaq: CTIC ; MTAX) announced ... the journal CANCER demonstrate that the,addition of radioimmunotherapy (RIT) to ...
Other Medicine Technology:Northwestern Memorial Transplant Program Initiates New Study 2Northwestern Memorial Transplant Program Initiates New Study 3Northwestern Memorial Transplant Program Initiates New Study 4Phase II Study of Zevalin(R) Consolidation Following Fludarabine and Mitoxantrone Chemotherapy Results in 100 Percent Complete Remission Rate and 89 Percent Three-Year Progression Free Survival in Patients with Previously Untreated Non-Follicular Indolent 2Phase II Study of Zevalin(R) Consolidation Following Fludarabine and Mitoxantrone Chemotherapy Results in 100 Percent Complete Remission Rate and 89 Percent Three-Year Progression Free Survival in Patients with Previously Untreated Non-Follicular Indolent 3Phase II Study of Zevalin(R) Consolidation Following Fludarabine and Mitoxantrone Chemotherapy Results in 100 Percent Complete Remission Rate and 89 Percent Three-Year Progression Free Survival in Patients with Previously Untreated Non-Follicular Indolent 4Phase II Study of Zevalin(R) Consolidation Following Fludarabine and Mitoxantrone Chemotherapy Results in 100 Percent Complete Remission Rate and 89 Percent Three-Year Progression Free Survival in Patients with Previously Untreated Non-Follicular Indolent 5For use with N4096 R, N4097 R and N4098 R. 18 mm wide x 167 mm long. Ten per package. Designated most popular model or size....
4 mm blade. Flat handle....
10 mm blade, angled left. Flat handle....
Double-ended. Blades set at 45 and 90 degrees. Hexagonal handle....
Medicine Products:Biology NavigationMedical Navigation